138 related articles for article (PubMed ID: 15627430)
21. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
[TBL] [Abstract][Full Text] [Related]
22. Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory.
Daniel JM; Hulst JL; Lee CD
Neuroscience; 2005; 132(1):57-64. PubMed ID: 15780466
[TBL] [Abstract][Full Text] [Related]
23. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats.
Kelley BM; Porter JH
Pharmacol Biochem Behav; 1997 Aug; 57(4):707-19. PubMed ID: 9258998
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
[TBL] [Abstract][Full Text] [Related]
25. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.
Machová E; Jakubík J; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Jul; 322(1):316-23. PubMed ID: 17446301
[TBL] [Abstract][Full Text] [Related]
26. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
[TBL] [Abstract][Full Text] [Related]
27. A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type.
Kitaichi K; Day JC; Quirion R
Eur J Pharmacol; 1999 Oct; 383(1):53-6. PubMed ID: 10556681
[TBL] [Abstract][Full Text] [Related]
28. Medial septal galanin and acetylcholine: influence on hippocampal acetylcholine and spatial learning.
Elvander E; Ogren SO
Neuropeptides; 2005 Jun; 39(3):245-8. PubMed ID: 15944017
[TBL] [Abstract][Full Text] [Related]
29. Involvement of nicotinic and muscarinic acetylcholine receptors on striatal HgCl2-induced dopamine release in freely moving rats.
Vidal L; Durán R; Faro LR; Alfonso M
Toxicol Lett; 2008 May; 178(3):181-4. PubMed ID: 18439770
[TBL] [Abstract][Full Text] [Related]
30. The facilitating effect of systemic administration of Kv7/M channel blocker XE991 on LTP induction in the hippocampal CA1 area independent of muscarinic activation.
Song MK; Cui YY; Zhang WW; Zhu L; Lu Y; Chen HZ
Neurosci Lett; 2009 Sep; 461(1):25-9. PubMed ID: 19463897
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia.
Johnson DE; Yamazaki H; Ward KM; Schmidt AW; Lebel WS; Treadway JL; Gibbs EM; Zawalich WS; Rollema H
Diabetes; 2005 May; 54(5):1552-8. PubMed ID: 15855345
[TBL] [Abstract][Full Text] [Related]
33. Muscarinic m4 receptor activation by some atypical antipsychotic drugs.
Zeng XP; Le F; Richelson E
Eur J Pharmacol; 1997 Mar; 321(3):349-54. PubMed ID: 9085047
[TBL] [Abstract][Full Text] [Related]
34. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats.
Karanth S; Liu J; Ray A; Pope C
Toxicology; 2007 Oct; 239(3):167-79. PubMed ID: 17707571
[TBL] [Abstract][Full Text] [Related]
36. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
Sato M; Ago Y; Koda K; Nakamura S; Kawasaki T; Baba A; Matsuda T
Eur J Pharmacol; 2007 Mar; 559(2-3):155-60. PubMed ID: 17258195
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic M(3) facilitation of acetylcholine release from rat myenteric neurons depends on adenosine outflow leading to activation of excitatory A(2A) receptors.
Vieira C; Duarte-Araújo M; Adães S; Magalhães-Cardoso T; Correia-de-Sá P
Neurogastroenterol Motil; 2009 Oct; 21(10):1118-e95. PubMed ID: 19470085
[TBL] [Abstract][Full Text] [Related]
38. Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788.
Lachowicz JE; Duffy RA; Ruperto V; Kozlowski J; Zhou G; Clader J; Billard W; Binch H; Crosby G; Cohen-Williams M; Strader CD; Coffin V
Life Sci; 2001 Apr; 68(22-23):2585-92. PubMed ID: 11392630
[TBL] [Abstract][Full Text] [Related]
39. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
Miller AD; Forster GL; Yeomans JS; Blaha CD
Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
[TBL] [Abstract][Full Text] [Related]
40. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents.
Bymaster FP; Felder CC
Mol Psychiatry; 2002; 7 Suppl 1():S57-63. PubMed ID: 11986996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
